Advarra Acquires Forte

Genstar Capital Acquires Advarra from Linden Capital Partners

June 6, 2019

Healthcare Services

Genstar Capital has signed and completed a definitive agreement to acquire Advarra, a leading provider of IRB, IBC and research compliance services, from Linden Capital Partners; Linden intends to reinvest as a minority investor upon closing. Advarra, headquartered in Columbia, Maryland, serves pharma, biotech, medical device companies, CROs and academic medical centers (relationships with over 3,200 institutional sites); Genstar plans to expand Advarra’s capabilities and pursue organic growth and strategic acquisitions.

Advarra Acquires Bio-Optronics from Mainsail Partners

March 9, 2021

Software

Advarra has acquired Bio-Optronics, the maker of the CCTrialSuite clinical trial management system (CTMS), from growth equity firm Mainsail Partners. The acquisition expands Advarra's site-focused technology portfolio, broadens its coverage of site networks and health systems, and enhances capabilities for connecting sponsors, CROs and research sites.

Advarra Acquires IntegReview IRB

November 9, 2020

Healthcare Services

Advarra has acquired IntegReview IRB, an AAHRPP-accredited central IRB based in Austin, Texas. The acquisition expands Advarra's IRB and early-phase clinical research capabilities, establishes its first office in the southern U.S., and will be integrated into Advarra over approximately six months.

Advarra Acquires YourEncore

January 7, 2021

Healthcare Services

Advarra has acquired YourEncore, a provider of drug development and commercialization advisory and consulting services. The acquisition expands Advarra's consulting capabilities—combining YourEncore's centers of excellence in quality, regulatory, and clinical with Advarra's IRB, IBC review and clinical site technology offerings to better serve biopharmaceutical sponsors, device manufacturers and academic medical centers.

Blackstone and CPP Investments Acquire Majority Stake in Advarra

June 10, 2022

Healthcare Services

Private equity funds managed by Blackstone and Canada Pension Plan Investment Board (CPP Investments) signed a definitive agreement to make a majority investment in Advarra, a provider of regulatory, compliance and clinical trial technology solutions. Existing shareholders Genstar Capital and Linden Capital Partners — along with management — will remain significant investors as the new partners support Advarra’s next growth phase and invest in new services, data, and software capabilities.

Advarra Acquires IRB Company, Inc. (IRBco)

April 20, 2020

Healthcare Services

Advarra, a leading provider of IRB, IBC, research technology and compliance services, has acquired IRB Company, Inc. (IRBco), an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981. The acquisition expands Advarra’s integrated IRB capabilities and institutional reach across the clinical research ecosystem.